SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Crucell N.V. (CRXL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
560 26 0 CRXL
Emcee:  Jongmans Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
535Pfizer has no plans to buy Astellas, correct? ;-)scaram(o)uche-1/27/2009
534Well we now know the minimum price management has set on the company - 20 euros nigel bates-1/26/2009
533<reply> Hindsight is 40/40 (Twice as good as 20/20). Don't forget PFkenhott-1/26/2009
532PFE takes out WYE and WYE drops the fishing line to CRXL. Looks like the WYE tekenhott-1/26/2009
531Correction. Forgot "impact of the" before "pending", so it fred hayes-1/23/2009
530Looks like a deal, I'm surprised. So, anyone who knows pfe is welcome to spefred hayes-1/23/2009
529JANUARY 23, 2009, 3:26 A.M. ET Pfizer in Talks to Buy Wyeth By MATTHEW KARNITSCkenhott-1/23/2009
528Betcha pfe will never be able to buy wye for $60 billion. I think it will take fred hayes-1/22/2009
527<i>Pfizer in talks to buy Wyeth, deal could top $60 bln- WSJ</i> rescaram(o)uche-1/22/2009
526<will get your 2B> 2B or not 2B, that is the question. I follow the cowakenhott-1/9/2009
525Ashley: Define reasonable. No is the best answer that I can think of. :-) I scaram(o)uche-1/8/2009
524<i>won't any company buying the PER.C6 technology be required to make DewDiligence_on_SI-1/8/2009
523That's a point, but won't any company buying the PER.C6 technology be reA.J. Mullen-1/8/2009
522Cell platforms are weird. Once something passes regulatory sniffing and a long scaram(o)uche-1/8/2009
521<i> Anything under 2bn (euros) would be a disappointment.</i> You&#A.J. Mullen-1/8/2009
520Would be nice if someone like Merck took an interest.rkrw-1/8/2009
519>>I am not sure you will get your 2B << Neither am I, but 10x revennigel bates-1/8/2009
518I had a couple of shares taken out late yesterday on a limit sell. The leak gotkenhott-1/8/2009
517Anything under 2bn (euros) would be a disappointment.nigel bates-1/7/2009
516I think that there would be multiple bidders at that price, and that it will go scaram(o)uche-1/7/2009
515I guess the comma makes it do that. Try this: Message 25305954sjemmeri-1/7/2009
514That link took me to a general SI page. There must be expectation of a higher bA.J. Mullen-1/7/2009
513Per Message 25305954, maybe still a chance for higher bids. That would be nice.sjemmeri-1/7/2009
512I just noticed the jump in CRXL price on my screen after the close. I think thaLJM-1/7/2009
511Wyeth in talks to buy vaccine maker Crucell: WSJ By Wallace Witkowski Last updascaram(o)uche-1/7/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News